Cite
HARVARD Citation
Cohen-Barak, O. et al. (2021). Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach. Cephalalgia. pp. 1065-1074. [Online].